Generics co Ani Pharm SP goes from $6.00 to $55 in a yrANI Pharmaceuticals (NASDAQ:ANIP) has transformed itself over the last 18 months. The company has successfully completed a reverse merger in June 2013, and its share price has increased from $6 at the time of the reverse merger to over $50 in early 2015.
A brief overview of the events that have driven ANI's share price higher in the last 18 months
Let us look at what were the main drivers for ANI's rapid share price advance since June 2013 (you can also see how the developments affected ANI's share price in the chart below):
- BioSante and ANI Pharmaceuticals complete a reverse merger in June 2013.
- On December 26, 2013, the company announces the acquisition of 31 generic products from Teva (NYSE:TEVA) for $12.5 million in cash plus a percentage of future sales. The acquisition effectively expanded the company's addressable market by $860 million.